TNF and systemic sclerosis: In SSc, this crosslink is disrupted, and the final result is an upregulation of Transforming Growth Factor-β (TGF-β) signaling and the release of peptides with Damage-Associated Molecular Pattern (DAMP) properties, along with tumor necrosis factor (TNF), which perpetuate the inflammation [34].